REVB Revelation Biosciences, Inc.

NASDAQ
$0.87

Revelation Biosciences, Inc. (REVB) is expected to report earnings on November 5, 2026, after the market close. The consensus earnings estimate is a loss of $0.88 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -23.0% since its last earnings release on August 6, 2026.

Revelation Biosciences Missed Consensus Estimates
Thursday, August 6, 2026 · 12:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 5
Thursday · After Close
Earnings Whisper
-
vs ($0.88)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $1.04

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Revelation Biosciences, Inc.

Revelation Biosciences, Inc. is a life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.